NCT04268602

Brief Summary

Failed Back Surgery Syndrome is described as chronic pain in the low back and/or legs after a spinal procedure. It is estimated that %10 - 40 of the patients who had spinal surgery will have Failed Back Surgery Syndrome. The aim of this study is to research whether intradermal injection of the local anesthetic on the operation scar area and the area in which pain referred to in patients with Failed Back Surgery Syndrome has effects on pain and functionality or not.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 13, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

July 30, 2020

Status Verified

July 1, 2020

Enrollment Period

6 months

First QC Date

January 10, 2020

Last Update Submit

July 29, 2020

Conditions

Keywords

FBSSFailed Back Surgery SyndromeChronic Painlocal anestheticIntradermal Injection

Outcome Measures

Primary Outcomes (2)

  • Change in Visual Analog Pain Scale scores

    Visual analog scale for measurement of pain. Minimum-maximum scores are 0-10. Higher scores mean worse outcome

    baseline, immediately after the intervention, 1 month

  • Change in OSWESTRY Disability Index scores

    Low Back Pain Disability Questionnaire. Minimum-maximum scores are 0-100. Higher scores mean worse outcome

    baseline, immediately after the intervention, 1 month

Secondary Outcomes (3)

  • Change in Hospital anxiety and depression scores

    baseline, immediately after the intervention, 1 month

  • change in modified schober test measurement

    baseline, immediately after the intervention, 1 month

  • change in Lateral hand to ground test measurement

    baseline, immediately after the intervention, 1 month

Study Arms (2)

Intervention Group

EXPERIMENTAL

intradermal 1% lidocain injection 4 cc+ exercise and transcutaneous electrical nerve stimulation

Other: local anesthetic injection

Control Group

NO INTERVENTION

exercise and transcutaneous electrical nerve stimulation

Interventions

1% lidocaine

Also known as: exercise and transcutaneous electrical nerve stimulation
Intervention Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with failed back surgery syndrome
  • years of age
  • visual analogue pain score\> 4 to be

You may not qualify if:

  • Mental problems
  • Having a disease affecting the central nervous system or peripheral nervous system
  • Fixation operation to the lumbar region
  • Physical therapy in the lumbar region within the last 3 months
  • Injection from the lumbar region in the last 3 months
  • Lidocaine allergy
  • Needle phobia.
  • Wound, infection, allergy, burn-type lesions in the area to be injected
  • Malignity history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Failed Back Surgery SyndromeChronic Pain

Interventions

Anesthetics, LocalExerciseTranscutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsBack PainPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic UsesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaElectric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor Dr, Head of Physical Medicine and Rehabilitation Department

Study Record Dates

First Submitted

January 10, 2020

First Posted

February 13, 2020

Study Start

September 1, 2020

Primary Completion

March 1, 2021

Study Completion

July 1, 2021

Last Updated

July 30, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share